NEW YORK, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative ...
Representative visualization features of the GseaVis R package showing enhanced GSEA plots, multi-pathway comparisons, heatmap annotations, and circular layout options for comprehensive gene set ...
Over the past 15 years scientists have identified hundreds of regions in the human genome associated with heart attack risk. However, efficient ways to explore how these genetic variants are ...
For decades, geneticists have known that most common illnesses are not caused by a single rogue gene but by intricate constellations of DNA variants acting together in specific cells. Now a new ...
In a highly anticipated article, FDA officials Vinay Prasad, M.D., and Martin Makary, M.D., outlined a novel regulatory pathway that could trigger a seismic shift in how bespoke gene editing therapies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback